Tuesday, April 18, 2017
12:00 – 1:00pm
RI auditorium, Glen Site – E S1.1129
With the current push to transform Montréal into a hub for early phase research, there is a pressing need to explore the issues that researchers and research ethics boards (REB) encounter in Phase I trials.
In this two-part presentation, recent examples from healthy volunteer and oncology studies will be used to illustrate how protocol design and ethics review can be enhanced.

